company background image
6882

Changchun BCHT Biotechnology SHSE:688276 Stock Report

Last Price

CN¥57.50

Market Cap

CN¥23.7b

7D

3.3%

1Y

-41.3%

Updated

01 Oct, 2022

Data

Company Financials +
688276 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance1/6
Financial Health6/6
Dividends0/6

688276 Stock Overview

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines.

Changchun BCHT Biotechnology Co. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Changchun BCHT Biotechnology
Historical stock prices
Current Share PriceCN¥57.50
52 Week HighCN¥103.18
52 Week LowCN¥34.85
Beta0
1 Month Change-6.05%
3 Month Change-15.79%
1 Year Change-41.32%
3 Year Changen/a
5 Year Changen/a
Change since IPO-51.48%

Recent News & Updates

Shareholder Returns

688276CN BiotechsCN Market
7D3.3%1.9%-2.3%
1Y-41.3%-33.6%-19.2%

Return vs Industry: 688276 underperformed the CN Biotechs industry which returned -33.6% over the past year.

Return vs Market: 688276 underperformed the CN Market which returned -19.2% over the past year.

Price Volatility

Is 688276's price volatile compared to industry and market?
688276 volatility
688276 Average Weekly Movement5.4%
Biotechs Industry Average Movement5.1%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.2%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 688276 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 688276's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20041,226Wei Konghttps://www.bchtpharm.com

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines. Its products include live attenuated varicella vaccine, freeze-dried nasal spray flu vaccine mist, and human rabies vaccine (vero cells). The company was founded in 2004 and is based in Changchun, China.

Changchun BCHT Biotechnology Co. Fundamentals Summary

How do Changchun BCHT Biotechnology's earnings and revenue compare to its market cap?
688276 fundamental statistics
Market CapCN¥23.74b
Earnings (TTM)CN¥178.76m
Revenue (TTM)CN¥1.06b

132.8x

P/E Ratio

22.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
688276 income statement (TTM)
RevenueCN¥1.06b
Cost of RevenueCN¥202.56m
Gross ProfitCN¥858.07m
Other ExpensesCN¥679.31m
EarningsCN¥178.76m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.43
Gross Margin80.90%
Net Profit Margin16.85%
Debt/Equity Ratio0.0%

How did 688276 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

23%

Payout Ratio